These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21093001)

  • 1. Effects of hyperimmune equine plasma on clinical and cellular responses in a low-dose endotoxaemia model in horses.
    Forbes G; Church S; Savage CJ; Bailey SR
    Res Vet Sci; 2012 Feb; 92(1):40-4. PubMed ID: 21093001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and urine nitric oxide concentrations in horses given below a low dose of endotoxin.
    Bueno AC; Seahorn TL; Cornick-Seahorn J; Horohov DW; Moore RM
    Am J Vet Res; 1999 Aug; 60(8):969-76. PubMed ID: 10451207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral clenbuterol on the clinical and inflammatory response to endotoxaemia in the horse.
    Cudmore LA; Muurlink T; Whittem T; Bailey SR
    Res Vet Sci; 2013 Jun; 94(3):682-6. PubMed ID: 23462621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pentoxifylline, flunixin meglumine, and their combination on a model of endotoxemia in horses.
    Baskett A; Barton MH; Norton N; Anders B; Moore JN
    Am J Vet Res; 1997 Nov; 58(11):1291-9. PubMed ID: 9361895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation of the role of soluble CD14 in hospitalized, sick horses.
    Silva A; Wagner B; McKenzie HC; Desrochers AM; Furr MO
    Vet Immunol Immunopathol; 2013 Oct; 155(4):264-9. PubMed ID: 24011901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxemia in neonatal calves given antiserum to a mutant Escherichia coli (J-5).
    Morris DD; Cullor JS; Whitlock RH; Wickstrom M; Corbeil LB
    Am J Vet Res; 1986 Dec; 47(12):2554-65. PubMed ID: 3541706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of clinical and laboratory data with serum tumor necrosis factor activity in horses with experimentally induced endotoxemia.
    Morris DD; Crowe N; Moore JN
    Am J Vet Res; 1990 Dec; 51(12):1935-40. PubMed ID: 2085219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of miniature horses given endotoxin.
    Cargile JL; MacKay RJ; Dankert JR; Skelley L
    Am J Vet Res; 1995 Nov; 56(11):1451-9. PubMed ID: 8585655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endotoxemia in horses: protection provided by antiserum to core lipopolysaccharide.
    Morris DD; Whitlock RH; Corbeil LB
    Am J Vet Res; 1986 Mar; 47(3):544-50. PubMed ID: 3516025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pentoxifylline infusion on response of horses to in vivo challenge exposure with endotoxin.
    Barton MH; Moore JN; Norton N
    Am J Vet Res; 1997 Nov; 58(11):1300-7. PubMed ID: 9361896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of eltenac in horses with induced endotoxaemia.
    MacKay RJ; Daniels CA; Bleyaert HF; Bailey JE; Gillis KD; Merritt AM; Katz TL; Johnson JC; Thompson KC
    Equine Vet J Suppl; 2000 Jun; (32):26-31. PubMed ID: 11202378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyxin B protects horses against induced endotoxaemia in vivo.
    Barton MH; Parviainen A; Norton N
    Equine Vet J; 2004 Jul; 36(5):397-401. PubMed ID: 15253079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma endotoxin in horses presented to an equine referral hospital: correlation to selected clinical parameters and outcomes.
    Senior JM; Proudman CJ; Leuwer M; Carter SD
    Equine Vet J; 2011 Sep; 43(5):585-91. PubMed ID: 21496089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival of foals with experimentally induced Rhodococcus equi infection given either hyperimmune plasma containing R. equi antibody or normal equine plasma.
    Perkins GA; Yeager A; Erb HN; Nydam DV; Divers TJ; Bowman JL
    Vet Ther; 2002; 3(3):334-46. PubMed ID: 12447842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperleptinemia in horses: responses to administration of a small dose of lipopolysaccharide endotoxin in mares and geldings.
    Huff NK; Thompson DL; Mitcham PB; Storer WA
    J Anim Sci; 2010 Mar; 88(3):926-36. PubMed ID: 19966166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis.
    Bailey SR; Adair HS; Reinemeyer CR; Morgan SJ; Brooks AC; Longhofer SL; Elliott J
    Vet Immunol Immunopathol; 2009 Jun; 129(3-4):167-73. PubMed ID: 19091426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tumor necrosis factor antibody given to horses during early experimentally induced endotoxemia.
    Barton MH; Bruce EH; Moore JN; Norton N; Anders B; Morris DD
    Am J Vet Res; 1998 Jun; 59(6):792-7. PubMed ID: 9622754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duration of in vivo endotoxin tolerance in horses.
    Holcombe SJ; Jacobs CC; Cook VL; Gandy JC; Hauptman JG; Sordillo LM
    Vet Immunol Immunopathol; 2016 May; 173():10-6. PubMed ID: 27090620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endotoxin-induced activation of equine platelets: evidence for direct activation of p38 MAPK pathways and vasoactive mediator production.
    Brooks AC; Menzies-Gow NJ; Wheeler-Jones C; Bailey SR; Cunningham FM; Elliott J
    Inflamm Res; 2007 Apr; 56(4):154-61. PubMed ID: 17522813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of dimethyl sulphoxide effects on initial response to endotoxin in the horse.
    Kelmer G; Doherty TJ; Elliott S; Saxton A; Fry MM; Andrews FM
    Equine Vet J; 2008 Jun; 40(4):358-63. PubMed ID: 18356128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.